Percutaneous drainage treatment of traumatic pancreatic rupture with pancreatic transection.
Management of traumatic pancreatic pseudocyst associated with pancreatic duct laceration is controversial. Surgical therapy has been clasically considered the treatment of choice for those pseudocysts. However, several authors have published good results with percutaneous drainage. Percutaneous drainage can be performed easily, with minimal complication and may facilitate the resolution of a pseudocyst. We present a case of a 16-year-old boy who sustained blunt abdominal trauma in a vehicle accident. A large pancreatic pseudocyst developed, with complete disruption of the main pancreatic duct. Percutaneous drainage under ultrasound guidance was performed and was associated with the administration of octreotide (to inhibit exocrine pancreatic secretion). The drainage flow decreased gradually until ceasing, and the pseudocyst disappeared.
Martinez-Ramos
David
D
General Surgery and Digestive System Service, Castellón General Hospital, Castellón, Spain. davidmartinez@comcas.es
Cifrián-Pérez
Manuel
M
García-Vila
José H
JH
Salvador-Sanchís
José Luis
JL
Hoashi
Jane S
JS
D000007:Abdominal Injuries / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy; D000063:Accidents, Traffic; D000293:Adolescent; D004322:Drainage / Q000379:methods*; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use; D010179:Pancreas / Q000000981:diagnostic imaging / Q000293:injuries*; D010192:Pancreatic Pseudocyst / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy*; D011860:Radiography, Abdominal; D012206:Rhabdomyolysis / Q000209:etiology; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014463:Ultrasonography; D014949:Wounds, Nonpenetrating / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy
D005765:Gastrointestinal Agents; D015282:Octreotide